Shares of Sangamo Therapeutics, Inc. (NASDAQ:SGMO – Get Free Report) reached a new 52-week high on Wednesday after HC Wainwright raised their price target on the stock from $5.00 to $10.00. HC ...

H.C. Wainwright raised the firm’s price target on Sangamo (SGMO) to $10 from $5 and keeps a Buy rating on the shares. The firm says the accelerated clinical development plan in Fabry disease may ...

Pre-earnings options volume in Sangamo (SGMO) is normal with calls leading puts 5:1. Implied volatility suggests the market is anticipating a move near 14.5%, or 26c, after results are released.

it signifies their reaction to recent developments related to Sangamo Therapeutics. This insight gives a snapshot of analysts' perspectives on the current state of the company. Rating: Providing a ...

RICHMOND, Calif., November 04, 2024--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the company has scheduled the release of its third ...

Here are the latest Springfield-area Week 9 high school football results and top performers from Friday and Saturday games.

The superstar stuffed the stat sheet in the blowout victory, and he also checked out of the fourth quarter early. The 25-year-old made five of his 13 three-point attempts after a three-game stint ...

Farmington's latest teams is one of the area power's best. Ahead of the Class 2A playoffs. let's look at the Farmers' ...

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the company has scheduled the release of its third quarter 2024 financial results after the market close ...